It's critical for cancer patients to get accurate diagnoses and effective treatment plans as quickly as possible. Yet, doctors often struggle with discerning exactly which form of the disease they are dealing with because they can't see the individual cells involved. Charlie Silver, CEO of Mission Bio, hopes to change that with more precise, comprehensive DNA testing.